Is Align Technology, Inc (NASDAQ: ALGN) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

ALGN belongs to the Healthcare sector of the NASDAQ while operating in the Medical Instruments & Supplies industry. The current market capitalization of Align Technology, Inc is $12.55B. A total of 0.82 million shares were traded on the day, compared to an average of 1.18M shares.

In the most recent transaction, Wright Emory bought 2,500 shares of ALGN for 232.94 per share on Nov 25 ’24. In a previous transaction on Aug 15 ’24, LARKIN C RAYMOND JR bought 6,500 shares at 235.33 per share. ALGN shares that Director owns now total 28,247.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ALGN has a high of $327.49 and a low of $141.74.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ALGN’s latest balance sheet shows that the firm has $1.17B in Cash & Short Term Investments as of fiscal 2021. There were $125.38M in debt and $1.92B in liabilities at the time. Its Book Value Per Share was $52.16, while its Total Shareholder’s Equity was $3.62B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALGN is Buy with a score of 4.38.

Most Popular

Related Posts